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ABSTRACT
Background: Ginseng species having been used in various traditional herbal therapies for many years in worldwide. 
In recent years, hyperlipidemia, hypercholesterolemia and obesity have become serious health problems. These are 
considered risk factor for metabolic and organic diseases such as atherosclerosis, fatty liver, diabetes. Therefore, 
prevention and treatment of these disorders are significant for ensuring comfortable and healthy life. It has been also 
stated that ginseng saponin suppressed liver enzyme increments caused by feeding with high cholesterol or fatty diet. 
The present study was undertaken to evaluate the effect of ginseng on liver enzymes of rats fed cholesterol-rich diet.
Materials, Methods & Results: In this study, 24 healthy adult male Wistar Albino rats were equally divided into 
three groups as control group (K), cholesterol group (C), and cholesterol + ginseng group (CG). The K group had ad 
libitum access to a standard rat diet for 40 days. The C and CG groups had ad libitum access to the same diet contain-
ing 5% cholesterol powder and 5% cholesterol + 1 g/kg Panax ginseng root powder, respectively, for 40 days. On 
the 40 th day of the study, blood samples were taken from 8 animals in each group. At the end of the study, plasma 
samples were analyzed for aspartase transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP), 
and gamma-glutamyltransferase (GGT) levels. The data were analyzed using one-way ANOVA. Differences among 
the groups were determined by Duncan’s multiple range test. In this study, the results showed that AST, ALT, GGT 
levels in cholesterol group significantly increased compared to control group but these parameters in cholesterol + 
ginseng group significantly decreased with ginseng administration compared to cholesterol group (P < 0.05). There 
was no significant difference among the groups with regard to ALP level. 
Discussion: AST, ALT, GGT and ALP are considered to be the markers of organ disfunction, indicator of cellular 
damage, cell leakage and the loss of cell membrane integritiy in the liver, kidney, heart and other organs. It was 
investigated effect of ginseng on some hepatic enzymes in rats fed a high cholesterol diet. In this study, feeding with 
the diet for 40 days resulted in elevation AST, ALT, GGT compared control levels (P < 0.05). In some studies, using 
high cholesterol diet caused hepatic injury in animal and human models. The harmful effects of high cholesterol 
on liver have been attributed to hepatic fibrosis, lipid peroxidation, increased endogenous oxidative stress, induc-
ing cellular damage and engendering hyperlipidemia. Increases in ALT, AST, GGT levels are thought to be due to 
oxidative stress related to hyperlipidemia in present study. In this study, treated with red Korean ginseng extract 
significantly prevented the elevations in AST, ALT, GGT levels (P < 0.05). The use of ginseng as an unconventional 
health treatment is gaining remarkable popularity among the people. It has been known that ginseng have assorted 
beneficial pharmacological effects and hypolipidemic, antidiabetic, antioxidative and immunostimulator effects have 
been stated among its pharmacological properties. These beneficial effects of ginseng on liver enzymes attributed to 
its active components known as ginsenosides. In the light of the findings, Panax ginseng root powder may be useful 
for hepatic damage and fibrosis associated with high cholesterol diet.
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INTRODUCTION
Hypercholesterolemia has been accepted as an 
important risk factor for coronary heart disease and 
atherosclerosis [5,40]. Cholesterol rich diet causes 
the quick deposition of lipid droplets in the liver [3]. 
Lipid accumulation results from an imbalance between 
hepatic fatty acid inflow, triglyceride synthesis and 
excretion. Therefore, lipid droplets are primarily stored 
as triglyceride [1]. There is an association between high 
cholesterol or fatty diet and hepatic injury as reported 
in previous study conducted in rabbit and rat models 
[4,7,45]. The harmful effects of cholesterol on liver 
and the relationship between receiving a high choles-
terol diet and hepatic fibrosis just has not been well 
understood. It has been suggested that myofibroblasts 
play primarily role in hepatic fibrosis. On the other 
hand, macrophages and mast cells participate in this 
process [14-16]. 
Ginseng (Panax ginseng C. A. Meyer, family 
Araliaceae) as medical plant has been commonly used 
in East Asian countries. Ginsenosides are the major 
components of ginseng [43]. These ginsenosides have 
various biological properties such as anti-inflammatory 
[46], anti-allergic [36], hypoglycemic and antidiabetic 
[23,34,42], hypocholesterolemic and hypolipidemic 
[26], anticarcinogenic [30,44,50] and hepatoprotective 
activities [13,28,29,48].  
Thus, it was the aim of this study to inves-
tigate the effect of ginseng on some liver enzymes 
(AST, ALT, ALP and GGT) in rats that were fed high 
cholesterol diet.
MATERIALS AND METHODS
In this study, 24 healthy adult male Wistar 
Albino rats were equally divided into three groups as 
control group (K), cholesterol group (C), and choles-
terol + ginseng group (CG). The K group had ad libitum 
access to a standard rat diet (Purina®)1 for 40 days. The 
C and CG groups had ad libitum access to the same diet 
containing 5% cholesterol powder2 and 5% cholesterol 
+ 1 g/kg Panax Ginseng root powder3, respectively, for 
40 days. On the 40 th day of the study, blood samples 
were taken from 8 animals in each group. In plasma 
samples, AST, ALT, ALP, GGT were determined in an 
ILAB 300 autoanalyser using ILAB300 kits. 
Statistical analysis
The data were analyzed using one-way ANO-
VA (SPSS 17). Differences among the groups were 
determined by Duncan’s multiple range test. Differ-
ences were considered significant at P < 0.05. 
RESULTS
At the end of 40 th day, AST, ALT, ALP, GGT 
levels in rats were presented in Table 1. In this study, 
AST, ALT, GGT levels in cholesterol group significant-
ly increased with feeding high cholesterol diet com-
pared to control group (P < 0.05, Table 1). Although, 
there are obviously increases in ALP level, difference 
is not important. The administration of ginseng to the 
high cholesterol diet significantly prevented elevations 
of AST, ALT, GGT levels compared to cholesterol 
group (P < 0.05, Table 1). 
Table 1. Effect of ginseng on plasma AST, ALT, ALP and GGT levels in rats fed cholesterol rich diet 
(Mean ± SE).
Group 
(n = 8)
AST 
U/L
ALT 
U/L
ALP 
U/L
GGT 
U/L
K 77.13 ± 4.84b 29.38 ± 2.58b 87.75 ± 6.40 8.16 ± 0.74b
C 101.25 ± 4.22a 38.75 ± 3.02a 103.13 ± 4.85 11.20 ± 0.56a
CG 86.88 ± 5.08b 30.63 ± 1.40b 93.63 ± 6.66 9.24 ± 0.49b
The difference between mean values with different superscripts in the same column is significant at the 
P < 0.05 level. 
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DISCUSSION
In this study, we investigated effect of ginseng 
on some hepatic enzymes in rats fed a high cholesterol 
diet. Feeding with the diet for 40 days resulted in el-
evation AST, ALT, GGT compared control levels (P < 
0.05, Table 1). In many studies, using a manipulated 
high cholesterol diet caused hepatic injury in animal 
and human models [10,11,17]. The hazardous effects 
of cholesterol itself on the liver have been attributed 
to hepatic fibrosis, lipid peroxidation, increased en-
dogenous oxidative stress, inducing cellular damage 
and engendering hyperlipidemia [15,16,33,41]. In our 
study, increases in ALT, AST, GGT levels are thought 
to be due to oxidative stress related to hyperlipidemia 
[6,9]. These enzymes are considered to be the markers 
of organ disfunction, indicator of cellular damage, cell 
leakage and the loss of cell membrane integritiy in the 
liver, kidney, heart and other organs [24,38,39,47].
It has been known that ginseng have assorted 
beneficial pharmacological effects and hypolipidemic, 
antidiabetic, antioxidative and immunostimulator 
effects have been stated among its pharmacological 
properties [2,49]. Ginseng products such as saponin 
type ginsenosides and non-saponin type poliacetylene 
panaxatriol, panaxadiol, oxidative polysaccharides and 
amino acids are responsible for its hypolipidemic and 
hypocholesterolemic effects [21,22,27]. It has been 
noted that ginseng treatments obviously decreased 
serum cholesterol and triglyceride levels in hyperlipid-
emic monkeys [8]. Hwang et al. [12] reported that gin-
seng saponins supplementation diminished the serum 
cholesterol level in rabbits fed with high cholesterol 
diet. On the other hand, it has been stated that ginsen-
osides have protective properties on cellular damage 
and membrane stabilities in several tissue [18,35]. In 
this study, treated with red Korean ginseng extract sig-
nificantly prevented the elevations in AST, ALT, GGT 
levels (P < 0.05, Table 1). In paralelly with our find-
ings, Kalkan et al. [18] observed that ginseng treatment 
significantly suppressed the increment in serum AST, 
ALT and GGT activities. Another study reported that 
crude ginsenosides extracted from stems and leaves of 
American ginseng reduced pancreatic lipase activity 
(in vitro), the plasma lipids and parametrial adipose tis-
sue weights in mice which feeding a high fat diet [32]. 
Also, some studies have suggested evidences about 
the protective effects of ginseng on kidney and liver 
damage [19,20,37]. However, it has been reported that 
ginsenosides are responsible for its hepatoprotective 
effect by destroy lipid peroxyl radicals and reactive 
oxygen species [25]. Liu et al. [31] demonstrated that 
American ginseng has effective roles in preventing of 
obesity, fatty liver and hypertriglyceridemia in mice 
fed with a high-fat diet. 
In conclusion, our findings suggest that Panax 
ginseng root powder can prevent hepatic damage and 
fibrosis following feeding with high cholesterol diet. 
In our study, the reducing effect of ginseng on these 
enzymes might be related with both its hypocholester-
olemic and antioxidative effect.
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